FDA To Review Approval Of Norvasc Generic As 505 (b) (2) Gateway Is Tested In Court
In a move that could have broad ramifications for 505 (b) (2) generic drug approvals, the U.S. Food and Drug Administration has stayed its decision to allow Indian drug maker Dr....To view the full article, register now.
Already a subscriber? Click here to view full article